CD8A and acute myeloid leukemia: The proportion of TIGIT+CD8+T cells is increased in peripheral blood collected from acute myeloid leukemia (AML) patients, and it becomes more evident in patients with primary refractory disease and leukemia relapse post-allogeneic stem-cell transplantation [49].